TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0180
0.00 (0.00%)
Apr 14, 2026, 2:48 PM AEST
TrivarX Market Cap
TrivarX has a market cap or net worth of 20.77 million as of April 14, 2026. Its market cap has increased by 161.86% in one year.
Market Cap
20.77M
Enterprise Value
17.44M
Revenue
-95.36K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since July 2, 2001, TrivarX's market cap has increased from 11.57M to 20.77M, an increase of 79.50%. That is a compound annual growth rate of 2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 20.77M | -5.26% |
| Dec 31, 2025 | 21.92M | 194.71% |
| Dec 30, 2024 | 7.44M | -26.66% |
| Dec 29, 2023 | 10.14M | 52.72% |
| Dec 28, 2022 | 6.64M | -41.41% |
| Dec 30, 2021 | 11.34M | 5.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mach7 Technologies | 70.50M |
| Beamtree Holdings | 43.60M |
| PainChek | 37.62M |
| Emyria | 37.10M |
| Vitasora Health | 36.85M |
| ImExHS | 21.63M |
| Resonance Health | 20.52M |
| Intelicare Holdings | 14.29M |